Recurrence or survival information was not available in their cohort.8 We found overlapping DFS and OS curves for patients with HER2 IHC 2+ and HER2 IHC 0/1+ results among patients with 2018 ASCO/CAP ISH group 4 breast cancer. Here, ERBB2 is linked to breast cancer.